Evidence map›Paper›PMID 41559773›Full record

ArticleCell communication and signaling : CCS2026

Peripheral lysosome levels dictate mTORC1 inactivation even when catabolically impaired.

Huy Quang Dang, Therése Forssén, Spyridon Pantelios, Aisegkioul Nteli Chatzioglou, Ewa Kurzejamska, C Theresa Vincent, Yasir Ibrahim, Anders P Mutvei

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Huy Quang DangDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
Therése Forssén *Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
Spyridon Pantelios *Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
Aisegkioul Nteli ChatzioglouDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
Ewa KurzejamskaDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
C Theresa VincentDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
Yasir IbrahimAraucaria Laboratories, Inc., New York, USA.
Anders P MutveiDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden. anders.mutvei@ki.se.

Funding

Translation regulation of the mesenchymal transition by the rRNA and mRNA m6A axisR01CA270241 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Clara Theresa Vincent · 2022 to 2026
$2.1M
NCI NIH HHS R01 CA270241
6 · The paper itself

Abstract

The mechanistic target of rapamycin complex 1 (mTORC1) is a central driver of cell growth that is frequently hyperactivated in cancer. While mTORC1 is activated at the lysosomal surface in response to growth factors and amino acids, the processes governing its inactivation are not fully understood. Here, we report that sustained mTORC1 suppression during leucine or arginine starvation requires the translocation of peripheral lysosomes to the perinuclear region. Our data suggest that a pool of mTOR remains active at peripheral lysosomes during starvation, and that increased spatial separation between lysosomes and the plasma membrane attenuates PI3K/Akt signaling-thereby reducing inputs that otherwise maintain mTORC1 activity. Consequently, preventing lysosome translocation and increasing peripheral lysosome levels sustains mTORC1 signaling during prolonged starvation in a PI3K/Akt-dependent manner independently of autophagy. Under these conditions, mTORC1 signaling persists even when lysosomal catabolism is perturbed by chloroquine or concanamycin A. Collectively, these data indicate that the peripheral lysosome pool, even when catabolically impaired, can sustain mTORC1 signaling under nutrient scarcity, by modulating PI3K/Akt signaling input to the pathway. These observations identify peripheral lysosome levels as a critical determinant of mTORC1 inactivation during nutrient stress and may have implications for diseases with aberrant mTORC1 signaling, including cancer.

Indexed as

LysosomesMechanistic Target of Rapamycin Complex 1TOR Serine-Threonine KinasesAnimalsArginineAutophagyHumansLeucineMultiprotein ComplexesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionArginineLeucineMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesAmino acid deprivationCatabolically impaired lysosomesLysosome positioningMTORC1PI3K-Akt signalingRab7Rap1

Identifiers

PMID41559773
PMCPMC12849086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.